Halozyme Therapeutics, Inc.
HALO · Healthcare · $13.1B
After-hours $107.39+0.42%
Price
$79.45
$111.6
Jul 2, 26Sep 29, 26
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
RevenueOperating IncomeNet Income
9/'26
Revenue$482M+0.3%
6/'26 vs prev quarter
Company Health
Market Cap$13.1B
Operating Margin+56.8%
Cash on Hand$231M1.8% of market cap
Free Cash Flow$393M3.0% of market cap
Among 327 Biotechnology peers
LowMedianHigh
PSR7.9xmedian 11.7xPER31.7xmedian 14.9xPBR91.2xmedian 2.1xROE+288.1%median -54.5%
